Physicians

This pocket guide is intended to assist clinicians in managing patients with HIV and  LTBI, and drug-susceptible pulmonary TB disease. The guide includes signs and symptoms, adult dosing, dosage forms, drug-drug interactions, side effects, and patient counseling points.

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

This pocket card provides information on the treatment of drug-susceptible TB disease. The pocket card is adapted from the 2016 Official American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

This poster is intended to encourage health care workers to advise clients that if conditions of tuberculosis (TB) symptoms last more than 2-3 weeks, to avoid group settings and see a medical provider immediately.

This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.

This Public Health Grand Rounds session discusses how more patients can benefit from advances in diagnostic and treatment options, resulting in an overall reduction in morbidity from MDR TB. The session also explores the role of CDC, WHO, and other partners in combating the public health epidemic.

This report highlights opportunities for health department infectious disease programs to address a range of drug user health issues, identifies potential collaborators and provides recommendations for health department programs to consider to best meet the comprehensive health needs of people who inject drugs.

This guide includes WHO recommendations on screening and treatment of pre-cancer lesions and on HPV vaccination made through April 2014, taking account of relevant evidence-based findings published up to December 2013; emerging practices that are still being evaluated are also noted in this publication. This guide, which replaces the 2006 edition, has two new chapters, one newly organized chapter, and two substantially revised chapters. The new chapters include: Essentials for cervical a=cancer prevention and control programmes; and HPV vaccination.

This report outlines opportunities for leadership engagement that promotes core public health, with case examples specific to STD prevention. The opportunities in this report fall under four areas: partnerships, payment, workforce, and surveillance.

This report outlines a collection of STD resources for health officials that may offer innovative solutions for reducing infectious diseases in a dynamic healthcare environment.